Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies
![Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies](https://www.ohe.org/wp-content/uploads/2020/06/Simon-Cover-150x150.png)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.